Vaxtex Cotfab Limited (NSE:VCL)
India · Delayed Price · Currency is INR 1.340
+0.030 (2.29%)
Jun 16, 2026, 3:27 PM IST
Vaxtex Cotfab Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 111.66 | 52.53 | 166.2 | 756.22 | 619.07 |
Other Revenue | - | - | 0.34 | 5.31 | - |
| 111.66 | 52.53 | 166.54 | 761.53 | 619.07 | |
Revenue Growth (YoY) | 112.56% | -68.46% | -78.13% | 23.01% | 136.70% |
Cost of Revenue | 87.01 | 50.56 | 218.64 | 706.91 | 540.51 |
Gross Profit | 24.66 | 1.98 | -52.1 | 54.62 | 78.56 |
Selling, General & Admin | 1.82 | 0.93 | 2.56 | 13.04 | 14.9 |
Other Operating Expenses | 3.86 | 5.87 | 9.89 | 37.71 | 33.55 |
Operating Expenses | 5.9 | 7.84 | 13.98 | 53.53 | 51.44 |
Operating Income | 18.76 | -5.87 | -66.08 | 1.09 | 27.12 |
Interest Expense | -0.73 | -1.13 | -0.66 | -6.31 | -10.79 |
Interest & Investment Income | - | 16.07 | 4.92 | 3.61 | 3.76 |
Other Non Operating Income (Expenses) | 32.59 | - | -0 | -0 | -0 |
EBT Excluding Unusual Items | 50.62 | 9.08 | -61.82 | -1.62 | 20.09 |
Gain (Loss) on Sale of Investments | - | -5.05 | - | -2.34 | - |
Gain (Loss) on Sale of Assets | - | - | -26.53 | - | - |
Other Unusual Items | - | 0.09 | - | 15.54 | - |
Pretax Income | 50.62 | 4.12 | -88.34 | 11.59 | 20.09 |
Income Tax Expense | -4.64 | -4.72 | - | 0.27 | 5.23 |
Net Income | 55.26 | 8.84 | -88.34 | 11.32 | 14.86 |
Net Income to Common | 55.26 | 8.84 | -88.34 | 11.32 | 14.86 |
Net Income Growth | 525.34% | - | - | -23.82% | 733.32% |
Shares Outstanding (Basic) | 184 | 184 | 151 | 103 | 100 |
Shares Outstanding (Diluted) | 184 | 184 | 151 | 103 | 100 |
Shares Change (YoY) | 0.24% | 22.07% | 46.02% | 2.69% | - |
EPS (Basic) | 0.30 | 0.05 | -0.59 | 0.11 | 0.15 |
EPS (Diluted) | 0.30 | 0.05 | -0.59 | 0.11 | 0.15 |
EPS Growth | 525.00% | - | - | -25.81% | 733.34% |
Free Cash Flow | -16.92 | 12.3 | -131.36 | -109.22 | 63.81 |
Free Cash Flow Per Share | -0.09 | 0.07 | -0.87 | -1.06 | 0.64 |
Gross Margin | 22.08% | 3.76% | -31.28% | 7.17% | 12.69% |
Operating Margin | 16.80% | -11.17% | -39.67% | 0.14% | 4.38% |
Profit Margin | 49.48% | 16.82% | -53.04% | 1.49% | 2.40% |
Free Cash Flow Margin | -15.15% | 23.41% | -78.87% | -14.34% | 10.31% |
EBITDA | 18.98 | -4.83 | -64.55 | 3.87 | 30.12 |
EBITDA Margin | 17.00% | -9.19% | -38.76% | 0.51% | 4.87% |
D&A For EBITDA | 0.23 | 1.04 | 1.53 | 2.79 | 2.99 |
EBIT | 18.76 | -5.87 | -66.08 | 1.09 | 27.12 |
EBIT Margin | 16.80% | -11.17% | -39.67% | 0.14% | 4.38% |
Effective Tax Rate | - | - | - | 2.32% | 26.03% |
Revenue as Reported | 144.25 | 63.82 | 171.46 | 765.13 | 622.83 |
Advertising Expenses | - | 0.07 | 0.45 | 0.06 | 0.02 |